Docetaxel (Taxotere) - an update

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.7, Iss.2, 1998-02, pp. : 273-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of the Combination of Docetaxel (Taxotere#174;) with Targeted Therapies in the Treatment of Solid Malignancies

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 982-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Docetaxel: An Update of its Use in Advanced Breast Cancer

By Figgitt D.P. Wiseman L.R.

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 621-651

Adis International

Access to resources Recommend Favorite

Necessity of interleukin-1 converting enzyme cascade in taxotere-initiated death signaling

By Suzuki A. Kawabata T. Kato M.

European Journal of Pharmacology, Vol. 343, Iss. 1, 1998-02 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

Docetaxel: Onycholysis: case report

Reactions Weekly, Vol. 1, Iss. 1215, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Docetaxel: Extravasation: case report

Reactions Weekly, Vol. 1, Iss. 1010, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite